Is Cardiff Oncology, Inc. CRDF stock halal to invest in?

No, as of February 2026, Cardiff Oncology, Inc. stock (CRDF) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Cardiff Oncology, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Cardiff Oncology, Inc. and alternative halal stock options within the Tabadulat app.

How often is Cardiff Oncology, Inc. CRDF reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Cardiff Oncology, Inc. CRDF monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Cardiff Oncology, Inc. CRDF pass the AAOIFI Non Permissible Income criteria?

No, as of February 2026, Cardiff Oncology, Inc. stock (CRDF) does not pass the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does Cardiff Oncology, Inc. CRDF pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of February 2026, Cardiff Oncology, Inc. stock (CRDF) passes the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments are below the acceptable threshold set by AAOIFI.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of February 2026, Cardiff Oncology, Inc. stock (CRDF) passes the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt is below the acceptable threshold set by AAOIFI.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

Cardiff Oncology, Inc.

NASDAQ

Shariah-Compliant

Not Shariah

CRDF

About

Cardiff Oncology, Inc.

CRDF

Cardiff Oncology Inc. is a biotechnology company focused on the development of precision medicine therapies for cancer treatment. The primary purpose of the organization is to create innovative oncological solutions that target specific genetic profiles of tumors, aiming to improve outcomes for cancer patients. Cardiff Oncology's flagship product, Onvansertib, is an oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor currently undergoing clinical trials for various malignancies, including colorectal cancer, castration-resistant prostate cancer, and acute myeloid leukemia. By applying a targeted therapeutic approach, the company seeks to address unmet needs in oncology therapies. Cardiff Oncology plays a significant role in the biotechnology sector by contributing to personalized cancer treatment research, which holds the potential to transform standard care practices. Based in San Diego, California, the company is actively involved in collaborations and research initiatives that explore novel treatment options, reinforcing its commitment to advancing medical science and improving patient quality of life.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

Website:

https://www.cardiffoncology.com

CRDF

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Cardiff Oncology, Inc.

About

Cardiff Oncology, Inc.

CRDF

Frequently asked questions

Is Cardiff Oncology, Inc. CRDF stock halal to invest in?

How often is Cardiff Oncology, Inc. CRDF reviewed for Shariah compliance?

Does Cardiff Oncology, Inc. CRDF pass the AAOIFI Non Permissible Income criteria?

Does Cardiff Oncology, Inc. CRDF pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Cardiff Oncology, Inc. CRDF stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.